The macular retinal ganglion cell layer as a biomarker for diagnosis and prognosis in multiple sclerosis: A deep learning approach
Acta Ophthalmologica · 2024-05 · 102 (3)
DOI: 10.1111/aos.15722 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Ophthalmologica, online erschienen am 10.06.2023. Verfasst von Alberto Montolío und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biomaterials Group, Aragon Institute of Engineering Research (I3A), University of Zaragoza, Zaragoza, Spain. Hauptthemen laut MEDLINE: Multiple Sclerosis, Deep Learning. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Instituto de Salud Carlos III, Ministerio de Ciencia, Innovación y Universidades, Ministerio de Economía y Competitividad.
Abstract (Originalsprache)
Purpose
The macular ganglion cell layer (mGCL) is a strong potential biomarker of axonal degeneration in multiple sclerosis (MS). For this reason, this study aims to develop a computer‐aided method to facilitate diagnosis and prognosis in MS.
Methods
This paper combines a cross‐sectional study of 72 MS patients and 30 healthy control subjects for diagnosis and a 10‐year longitudinal study of the same MS patients for the prediction of disability progression, during which the mGCL was measured using optical coherence tomography (OCT). Deep neural networks were used as an automatic classifier.
Results
For MS diagnosis, greatest accuracy (90.3%) was achieved using 17 features as inputs. The neural network architecture comprised the input layer, two hidden layers and the output layer with softmax activation. For the prediction of disability progression 8 years later, accuracy of 81.9% was achieved with a neural network comprising two hidden layers and 400 epochs.
Conclusion
We present evidence that by applying deep learning techniques to clinical and mGCL thickness data it is possible to identify MS and predict the course of the disease. This approach potentially constitutes a non‐invasive, low‐cost, easy‐to‐implement and effective method.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomaterials Group, Aragon Institute of Engineering Research (I3A), University of Zaragoza, Zaragoza, Spain.
- Mechanical Engineering Department, University of Zaragoza, Zaragoza, Spain.
- Ophthalmology Department, Miguel Servet University Hospital, Zaragoza, Spain.
- GIMSO Research and Innovation Group, Aragon Institute for Health Research (IIS Aragon), Zaragoza, Spain.
ORCID-Profile: Alberto Montolío, José Cegoñino, Elena Garcia-Martin, Amaya Pérez Del Palomar
Förderung
- Instituto de Salud Carlos III
- Ministerio de Ciencia, Innovación y Universidades
- Ministerio de Economía y Competitividad
Zitieren
APA
Montolío, A., Cegoñino, J., Garcia-Martin, E., & Pérez Del Palomar, A. (2024). The macular retinal ganglion cell layer as a biomarker for diagnosis and prognosis in multiple sclerosis: A deep learning approach. Acta Ophthalmologica, 102(3). https://doi.org/10.1111/aos.15722
Vancouver
Montolío A, Cegoñino J, Garcia-Martin E, Pérez Del Palomar A. The macular retinal ganglion cell layer as a biomarker for diagnosis and prognosis in multiple sclerosis: A deep learning approach. Acta Ophthalmologica. 2024;102(3). doi:10.1111/aos.15722
BibTeX
@article{Montolo2024,
author = {Montolío, Alberto and Cegoñino, José and Garcia-Martin, Elena and Pérez Del Palomar, Amaya},
title = {The macular retinal ganglion cell layer as a biomarker for diagnosis and prognosis in multiple sclerosis: A deep learning approach},
journal = {Acta Ophthalmologica},
year = {2024},
volume = {102},
number = {3},
doi = {10.1111/aos.15722}
}
EUVIMED